These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model. Gillespie DL, Aguirre MT, Ravichandran S, Leishman LL, Berrondo C, Gamboa JT, Wang L, King R, Wang X, Tan M, Malamas A, Lu ZR, Jensen RL. J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275 [Abstract] [Full Text] [Related]
26. Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles. Pan J, Ruan W, Qin M, Long Y, Wan T, Yu K, Zhai Y, Wu C, Xu Y. Sci Rep; 2018 Jan 18; 8(1):1117. PubMed ID: 29348670 [Abstract] [Full Text] [Related]
27. Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitis-like model rat. Kigasawa K, Kajimoto K, Hama S, Saito A, Kanamura K, Kogure K. Int J Pharm; 2010 Jan 04; 383(1-2):157-60. PubMed ID: 19732811 [Abstract] [Full Text] [Related]
28. Efficient intracellular delivery and multiple-target gene silencing triggered by tripodal RNA based nanoparticles: a promising approach in liver-specific RNAi delivery. Sajeesh S, Lee TY, Kim JK, Son DS, Hong SW, Kim S, Yun WS, Kim S, Chang C, Li C, Lee DK. J Control Release; 2014 Dec 28; 196():28-36. PubMed ID: 25251899 [Abstract] [Full Text] [Related]
32. Lipid-based Nanocarriers for siRNA Delivery: Challenges, Strategies and the Lessons Learned from the DODAX: MO Liposomal System. Oliveira ACN, Fernandes J, Gonçalves A, Gomes AC, Oliveira MECDR. Curr Drug Targets; 2019 Jun 28; 20(1):29-50. PubMed ID: 29968536 [Abstract] [Full Text] [Related]
33. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges. Gomes-da-Silva LC, Fonseca NA, Moura V, Pedroso de Lima MC, Simões S, Moreira JN. Acc Chem Res; 2012 Jul 17; 45(7):1163-71. PubMed ID: 22568781 [Abstract] [Full Text] [Related]
36. Development of a Liquid Crystal Formulation that Can Penetrate the Stratum Corneum for Intradermal Delivery of Small Interfering RNA. Kawai M, Ibaraki H, Takashima Y, Kanazawa T, Okada H. Mol Pharm; 2021 Mar 01; 18(3):1038-1047. PubMed ID: 33395310 [Abstract] [Full Text] [Related]
37. Progress in Topical siRNA Delivery Approaches for Skin Disorders. Aldawsari M, Chougule MB, Babu RJ. Curr Pharm Des; 2015 Mar 01; 21(31):4594-605. PubMed ID: 26362644 [Abstract] [Full Text] [Related]
38. Targeted GATA3 knockdown in activated T cells via pulmonary siRNA delivery as novel therapy for allergic asthma. Kandil R, Baldassi D, Böhlen S, Müller JT, Jürgens DC, Bargmann T, Dehmel S, Xie Y, Mehta A, Sewald K, Merkel OM. J Control Release; 2023 Feb 01; 354():305-315. PubMed ID: 36634709 [Abstract] [Full Text] [Related]
40. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. Aigner A. J Biotechnol; 2006 Jun 25; 124(1):12-25. PubMed ID: 16413079 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]